Difference between revisions of "Maribavir"
Jump to navigation
Jump to search
(various grammatical changes) |
DavidB4-bot (talk | contribs) (→Original Source: Spelling, grammar, and general fixes) |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | '''Maribavir''' (mar-I-buh-veer) is a substance that blocks the ability of viruses to make new viruses and infect cells. It is being studied in the prevention of cytomegalovirus infection in cancer patients who have had a donor stem cell transplant. It is a type of [[antiviral]] agent. | |
| − | [[ | + | {{Copyright Details (US Government)}} |
| + | ==Original Source== | ||
| + | *http://www.cancer.gov/dictionary/?searchTxt=maribavir | ||
| + | [[Category:Medicine]] | ||
Latest revision as of 14:14, June 24, 2016
Maribavir (mar-I-buh-veer) is a substance that blocks the ability of viruses to make new viruses and infect cells. It is being studied in the prevention of cytomegalovirus infection in cancer patients who have had a donor stem cell transplant. It is a type of antiviral agent.
| Copyright Details | |
|---|---|
| License: | This work is in the Public Domain in the United States because it is a work of the United States Federal Government under the terms of Title 17, Chapter 1, Section 105 of the U.S. Code |
| Source: | File available from the United States Federal Government. |